[Nitric oxide and heart failure]

Nihon Rinsho. 2004 Sep:62 Suppl 9:527-30.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Inhalation
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • Endothelial Cells / enzymology
  • Endothelial Cells / metabolism
  • Heart Failure / drug therapy*
  • Heart Failure / etiology*
  • Heart Failure / physiopathology
  • Humans
  • Isosorbide Dinitrate / therapeutic use
  • Myocytes, Cardiac / enzymology
  • Myocytes, Cardiac / metabolism
  • Nitric Oxide / administration & dosage
  • Nitric Oxide / biosynthesis
  • Nitric Oxide / physiology*
  • Nitric Oxide Donors / therapeutic use
  • Nitric Oxide Synthase / physiology
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Nitric Oxide Donors
  • Nitric Oxide
  • NOS1 protein, human
  • NOS2 protein, human
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Isosorbide Dinitrate